A patient has died in a mid-stage study of MacroGenics’ bispecific antibody lorigerlimab in gynecologic cancers, prompting ...

The FDA has placed a partial clinical hold on a cancer drug trial following four safety events, including one death, according to a Feb. 25 announcement from MacroGenics.  The partial hold pauses ...

Research shows that cancer survivors can lower their risk of death with increased physical activity. Here's what Black cancer ...

The FDA has approved the first combination, targeted regimen for previously untreated BRAF V600E mutation-positive metastatic ...

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...

By Dr. Priyom Bose, Ph.D. For many patients, the emotional toll of cancer can become a hidden risk factor, one that may influence survival as much as the disease itself. Study: Association of mental ...

More people than ever are surviving cancer, and death rates have decreased by 22 per cent in the past 50 years, but diagnoses ...

Early symptoms that mimic common ear and sinus conditions often lead to delayed diagnosis.

Lung cancer cells are able to take advantage of a person’s immune system, specifically T cells, to protect the tumor, according to new research recently published in Cancer Immunology Research.

Doctors say although screenings typically begin at the age of 45, they are seeing an increase in younger patients developing colon cancer.

MONTREAL — Jacques Poissant’s suffering stopped the day he asked his daughter if it would be “cowardly to ask to be helped to ...